We are live on
!
Find out more
DexCom
DXCM
DXCM
414 hedge funds and large institutions have $10.5B invested in DexCom in 2018 Q4 according to their latest regulatory filings, with 105 funds opening new positions, 153 increasing their positions, 117 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
102% more first-time investments, than exits
New positions opened: 105 | Existing positions closed: 52
57% more funds holding in top 10
Funds holding in top 10: 7 → 11 (+4)
31% more repeat investments, than reductions
Existing positions increased: 153 | Existing positions reduced: 117
14% more funds holding
Funds holding: 363 → 414 (+51)
3% less call options, than puts
Call options by funds: $25.8M | Put options by funds: $26.7M
4.33% less ownership
Funds ownership: 401.9% → 397.57% (-4.3%)
17% less capital invested
Capital invested by funds: $12.7B → $10.5B (-$2.19B)
Holders
414
Holders Change
+51
Holders Change %
+14.05%
% of All Funds
9.22%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.25%
New
105
Increased
153
Reduced
117
Closed
52
Calls
$25.8M
Puts
$26.7M
Net Calls
-$868K
Net Calls Change
+$6.93M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$231M |
| 2 |
HM
HealthCor Management
New York
|
+$126M |
| 3 |
BlackRock
New York
|
+$117M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$89.4M |
| 5 |
Two Sigma Advisers
New York
|
+$82.6M |
